1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow FHD: new trials by email Literature Review of FHD trials Research Report on FHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital Self-help Program for Functional Hypothalamic Amenorrhea (HEAL-FHA RCT) Psychoeduation for FHA, Treatment as Usual (TAU) - Hypothalamic Amenorrhea, Functional | Not applicable | Not yet recruiting | Karolinska Institutet | 70 | 2027-09-01 | 2026-11-12 |
| Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines Pertagen®, Revaxis® - Pertussis, Vaccine-Preventable Diseases | Phase 2 / Phase 3 | Unknown | University Hospital, Geneva | 100 | 2022-02-07 | 2022-01-18 |
Amenorrhea (1) · Vaccine-Preventable Diseases (1) · Whooping Cough (1)
Karolinska Institutet (1) · University Hospital, Geneva (1)
Sweden (1) · Switzerland (1)
2023 (1)